China SXT Pharmaceuticals (NASDAQ:SXTC) Shares Up 1.5% – Should You Buy?

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) rose 1.5% during trading on Thursday . The company traded as high as $0.36 and last traded at $0.34. Approximately 161,492 shares changed hands during trading, a decline of 80% from the average daily volume of 805,831 shares. The stock had previously closed at $0.34.

China SXT Pharmaceuticals Trading Up 1.5 %

The business’s 50 day moving average price is $0.48 and its 200-day moving average price is $0.77. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.60 and a quick ratio of 1.51.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Recommended Stories

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.